their services to all customers. The Company, leading distributor of medical device, is developing new products; medical software, together with plan to shift from distributor to manufacture to serve
approximately 5.30 Million Baht or 14.52% because of, customers waiting for the measures promoted by the government to issue a policy plan for a loan from a financial institution. Cost of Sales For financial
financial statements as of March 31, 2017 are as follows: Total assets Total liabilities Paid-up capital Retained losses 956,919,685 Baht 440,554,747 Baht 722,222,200 Baht 205,857,262 Baht 8. Financial Plan
8,449,868 8,479,860 7,346,538 32,458,147 7,266,594 (11.19) (1.09) Table 6: KCE New Plant Capacity (Maximum) 1Q 2019 1.70 million sq.ft /month 2Q 2019 (Plan) 1.70 million sq.ft /month 3Q 2019 (Plan) 1.85
million, an increase from previous year amount of THB 11.49 million or 29.93 per cent. Due to the improvement of benefits under retirement plan for employees who were employed by the Company for twenty
future cash flows, the terminal growth rate and discounted rate used in the assumptions are based on management of the subsidiary and indirect subsidiary’s judgment and past experience and business plan
Our Policies Strategic Plan Annual Report Stakeholders in the Capital Market The Foundation of the SEC Toward International Excellence International Relations Contact Us Complaint/Whistleblower Holiday
Our Policies Strategic Plan Annual Report Stakeholders in the Capital Market The Foundation of the SEC Toward International Excellence International Relations Contact Us Complaint/Whistleblower Holiday
Our Policies Strategic Plan Annual Report Stakeholders in the Capital Market The Foundation of the SEC Toward International Excellence International Relations Contact Us Complaint/Whistleblower Holiday
Our Policies Strategic Plan Annual Report Stakeholders in the Capital Market The Foundation of the SEC Toward International Excellence International Relations Contact Us Complaint/Whistleblower Holiday